| Reported | Consensus estimates | |||||
|---|---|---|---|---|---|---|
| Fiscal period | FY2024Jan '24 | FY2025Jan '25 | FY2026Jan '26 | FY2027Jan '27 | FY2028Jan '28 | FY2029Jan '29 |
| Revenue (B) | 1.60 | 1.39 | 1.21 | 1.08 | 1.13 | 1.19 |
| Growth YoY | −6.2% | −13.5% | −12.8% | −10.4% | +4.8% | +4.9% |
| High estimate | – | – | – | 1.08 | 1.13 | 1.19 |
| Low estimate | – | – | – | 1.08 | 1.13 | 1.19 |
| Analysts | – | – | – | 1 | 1 | 1 |
| EPS, adjusted | −8.28 | 0.41 | −3.71 | −4.65 | −2.15 | 0.50 |
| Growth YoY | n/m | n/m | −1004.9% | n/m | n/m | n/m |
| High estimate | – | – | – | −4.65 | −2.15 | 0.50 |
| Low estimate | – | – | – | −4.65 | −2.15 | 0.50 |
| Analysts | – | – | – | 1 | 1 | 1 |
Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.
| Firm | Analyst | Rating | Prev rating | Target | Prev target | Chg | Upside | Date |
|---|---|---|---|---|---|---|---|---|
| UBS | Jay Sole | Neutral | Neutral | $3.25 | $4.00 | −19% | +52% | Sep 9 |